(UroToday.com) PSA screening can reduce prostate cancer mortality. However, screening remains relatively underused in younger, healthy men, and overused in the older less healthy population. A retrospective cross-sectional study among men aged 50 years or older showed that between 2015 and 2018 there was no significant increase in the PSA-based prostate cancer screening. However, a significant increasing trend in shared decision making was observed, especially in men aged 55-69 years.1 In their study, Dr. Sigrid Carlsson and colleagues hypothesized that the widespread failure to follow well-accepted PSA-screening guidelines is because the recommended algorithms are relatively complex and primary care physicians lack tools to efficiently employ shared decision-making procedures in their busy practices. As a part of a larger project to develop and implement a digital clinical decision-support tool for PSA-screening for primary care physicians, they conducted a focus group to assess primary care physician’s attitudes toward PSA-screening algorithms, perceptions of using decision support tools and assessing the feasibility of implementing such a tool in clinic. The results of this study were presented by Dr. Carlsson at the AUA 2020 virtual annual meeting.